Will non-invasive, SNP-based prenatal screening (NIPT) be used by lower risk patient subgroups? What is the perspective of professional agencies on the use of cell-free fetal DNA testing?

Will non-invasive, SNP-based prenatal screening (NIPT) be used by lower risk patient subgroups? What is the perspective of professional agencies on the use of cell-free fetal DNA testing?

Will non-invasive, SNP-based prenatal screening (NIPT) eventually be used by lower risk patient subgroups, and if so why? What is the perspective of professional agencies on the use of cell-free fetal DNA testing?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Mike Ruma, MD, MPH, FACOG

Mike Ruma, MD, MPH, FACOG

Maternal–Fetal Medicine Specialist
Perinatal Associates of New Mexico
Albuquerque, NM